StockData
Stoke Therapeutics, Inc. logo

Stoke Therapeutics, Inc. (STOK) stock

STOKNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 6/30173% above fair value
$26.69+0.28 (+1.06%)

Close on Nov 18, 2026Market cap $1.72BP/E –Yield –

Stoke Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Stoke Therapeutics's market cap was $1.73B on Nov 11, 2026, against $1.70B a year earlier. Over the last 5 years it ranged from $167.87M to $2.15B, with a median of $619.66M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$1.73B-1.0%
2025Dec 31, 2025$1.75B+199.6%
2024Dec 31, 2024$583.94M+150.6%
2023Dec 29, 2023$232.98M-36.0%
2022Dec 30, 2022$363.91M-58.8%
2021Dec 31, 2021$882.36M-57.3%
2020Dec 31, 2020$2.07B+122.9%
2019Dec 31, 2019$926.75M–

More Stoke Therapeutics figures

See a number that looks wrong?